Merlin Thomas
0000-0003-0694-8743
MONASH UNIVERSITY
280 papers found
Refreshing results…
Into the light? Diabetic nephropathy and vitamin D
miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-β2 Expression
Candesartan Attenuates Diabetic Retinal Vascular Pathology by Restoring Glyoxalase-I Function
Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse
Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways
Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse
Lung Function and Risk of Type 2 Diabetes and Fatal and Nonfatal Major Coronary Heart Disease Events: Possible Associations With Inflammation
High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: Does NT-proBNP help to explain this association?
The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology
Assessment of kidney function in type 2 diabetes
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase
Cardiovascular Disease: What's All the AGE/RAGE About?
Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor
Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury
The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse
High-salt diet reveals the hypertensive and renal effects of reduced nephron endowment
Attenuation of diabetes-associated atherosclerosis with LR-90, a novel inhibitor of age formation
Preface: We are what we eat
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2002) 51, (3274-3282))
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy
Missing publications? Search for publications with a matching author name.